TheraTech, Inc.
🏢 View company profile →36Patents
0Active
36Granted
39Portfolio score
Filing activity: Nov 12, 1987 → Nov 5, 1997
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5139023A | Apparatus and method for noninvasive blood glucose monitoring | Human Necessities | 361 | Expired |
| US4863970A | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols | Human Necessities | 244 | Expired |
| US5985317A | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents | Human Necessities | 207 | Expired |
| US4925677A | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents | Human Necessities | 193 | Expired |
| US4855294A | Method for reducing skin irritation associated with drug/penetration enhancer compositions | Human Necessities | 181 | Expired |
| US5041292A | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents | Human Necessities | 164 | Expired |
| US5766620A | Buccal delivery of glucagon-like insulinotropic peptides | Human Necessities | 158 | Expired |
| US5626866A | Drug-containing adhesive composite transdermal delivery device | Human Necessities | 150 | Expired |
| US5780050A | Drug delivery compositions for improved stability of steroids | Human Necessities | 135 | Expired |
| US5346701A | Transmucosal delivery of macromolecular drugs | Human Necessities | 132 | Expired |
| US4849224A | Device for administering an active agent to the skin or mucosa | Human Necessities | 116 | Expired |
| US5152997A | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels | Human Necessities | 115 | Expired |
| US5849322A | Compositions and methods for buccal delivery of pharmaceutical agents | Human Necessities | 111 | Expired |
| US4983395A | Device for administering an active agent to the skin or mucosa | Human Necessities | 107 | Expired |
| US4888354A | Skin penetration enhancement using free base and acid addition salt combinations of active agents | Human Necessities | 103 | Expired |
| US5783208A | Transdermal drug delivery matrix for coadministering estradiol and another steroid | Human Necessities | 103 | Expired |
| US5601839A | Triacetin as a penetration enhancer for transdermal delivery of a basic drug | Human Necessities | 102 | Expired |
| US5662925A | Transdermal delivery system with adhesive overlay and peel seal disc | Human Necessities | 97 | Expired |
| US5952000A | Fatty acid esters of lactic acid salts as permeation enhancers | Human Necessities | 89 | Expired |
| US5460820A | Methods for providing testosterone and optionally estrogen replacement therapy to women | Human Necessities | 76 | Expired |
| US5834010A | Triacetin as a penetration enhancer for transdermal delivery of a basic drug | Human Necessities | 62 | Expired |
| US5395753A | Method for diagnosing rheumatoid arthritis | Physics | 61 | Expired |
| US5122383A | Sorbitan esters as skin permeation enhancers | Human Necessities | 46 | Expired |
| US5863555A | Buccal delivery of glucagon-like insulinotropic peptides | Human Necessities | 45 | Expired |
| US5164190A | Subsaturated transdermal drug delivery device exhibiting enhanced drug flux | Human Necessities | 40 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.